top of page
Image by AbsolutVision

Publications

Financing innovation and access to medical products.

Global Public Investment Network GPINMohga Kamal-Yanni (2023)

Should covid-19 vaccines and drugs be "not for profit"?

Mohga Kamal-Yanni (2022)

Series of podcasts on COVID19 in Arabic

Mohga Kamal-Yanni (2023)

Harmful Side Effects: How Drug Companies Undermine Global Health

Oliver Pearce and Mohga Kamal-Yanni (2018)

Report of the UN Secretary-General's High-Level Panel on Human Rights and Medicines

Mohga Kamal-Yanni (2016) 

Never Again: Building Resilient Health Systems and Learning From the Ebola Crisis

Mohga Kamal-Yanni (2015) 

Hepatitis C Drug Affordability

The Lancet Global Health, Vol. 3, No. 2, e73-e74. Mohga Kamal-Yanni (2015) 

Action to Preserve WHO's Core Medicines-Related Roles – 1 Year On

The Lancet, Vol. 381, Issue 9863, pages 293-294. Mohga Kamal-Yanni (2015) Philippa Saunders &,Mohga Kamal-Yanni (2013)

SALT, SUGAR, AND MALARIA PILLS: How the Affordable Medicine Facility-Malaria Endangers Public Health

Oxfam policy paper. Mohga Kamal-Yanni (2012) 

Urgent Need for WHO's Reform to Prioritise Core 

Lancet Vol. 379, pp.11878. Mohga Kamal-Yanni & Philippa Saunders (2012) 

Scaling-Up Malaria Treatment: A Review of the Performance of Different Providers

Malaria Journal 11:414. Mohga M Kamal-Yanni, Julien Potet & Philippa M Saunders (2012) 

Action to Preserve WHO's Core Functions Cannot Wait for Organisational Reform

Lancet, Vol.379, Issue 9813, pp.309. Mohga M Kamal-Yanni (2012) 

Open Letter to Lamberto Andreotti, Chief Executive Officer, Bristol-Myers Squibb

The Lancet Vol. 375, Issue 9733, pp.213. Mohga Kamal-Yanni, Kim Nichols, Esther Tallah, & Nelson Otwoma (2010)

Affordable Medicines Facility for Malaria: Reasonable or Rash?

The Lancet Vol. 375, Issue 9709, pp.121. Mohga Kamal-Yanni, (2010) 

Community Health Insurance Schemes in Armenia: Are They Reaching the Poor?

Health Policy and Planning; 24:209–216. Polonsky J, Balabanova D, McPake B, Poletti T, Vyas S, Ghazaryan O, Kamal Smith M. (2009) 

Ending the R&D Crisis in Public Health

Oxfam policy paper. Rohit Malpani, Corinna Heineke, Mohga Kamal Yanni (2008) 

Investing for Life, Meeting Poor People's Needs for Access to Medicines Through Responsible Business Practices 

Oxfam policy paper. Helena Viñes Fiestas, Sumi Dhanarajan, Rohit Malpani, Mohga Kamal-Yanni, Philippa Saunders & Stewart Atkins (2007) 

Access to Medicines: Why High Prices of New Medicines are a Disaster for Poor People and Public Health in Developing Countries

Vienna Medical Journal. Mohga Kamal Yanni (2007) 

Patients v Patients, Doha Plus 5

Oxfam policy paper. Malpani and Kamal Yanni (2007) 

Options for Scaling Up Community-Based Health Insurance for Rural Communities in Armenia

Joint publication by LSHTM, HSD, Oxfam. Tim Poletti, Dina Balabanova, Olga Ghazaryan, Mohga Kamal Yanni, Hasmik Kocharyan, Karen Arakelyan and Margarita Hakobyan (2007)

Facing the Health Workers Crisis in Developing Countries: A Call for Global Solidarity

WHO Bulletin. Mohga Kamal Smith & Nina Henderson (2006)

Editorial: HIV Special Issue

Gender and Development, Vol.14 No.1. Mohga Kamal smith, Finola Potter, Caroline Sweetman (March 2006)

Free Trade Agreement Between the USA and Thailand Threatens Access to HIV/AIDS Treatment

Oxfam briefing paper for Bangkok conference on HIV/AIDS. Mohga Kamal Smith (2004) 

TRIPS, Whose Interests Are Being Served?

The Lancet, Vol. 362, p. 260. Mohga Kamal Smith & Michael Bailey (2003)

Why Do Developing Countries Need Cheap Treatment?

Diabetes Voice, July 2003, Vol. 48, Issue 2. Mohga Kamal Smith (2003) 

Essential Drugs Concept is Needed Now More Than Ever

Royal Society of medicines. Mohga Kamal Smith (2003) 

New WHO Leader Should Keep Health of the Poor at the Heart of the Political Agenda

The Lancet, Vol. 361. Mohga Kamal Smith (2003) 

HIV, Age and Gender

Gender and Development. Mohga Kamal Smith (2002) 

Generic Competition, Price, and Access to Medicines: The Case of Antiretrovirals in Uganda

Oxfam briefing paper Number 26. Mohga Kamal Smith (2002) 

The Global Fund to Fight HIV/AIDS, TB and Malaria: False Hope or New Start?

Oxfam briefing paper no. 24. Mohga Kamal Smith (2002) 

Trade Systems in Less Developed Countries 

The Lancet, Vol. 357, p243. Mohga Kamal Smith & Ellen t’Hoen (2001) 

Gender and Health Monitoring and Evaluation 

Gender and Development.  Mohga Kamal Smith (2001) 

Patent Injustice

Oxfam Publication. Bailey M, Mayne, R, & Smith MK. (2001)

Global HIV/AIDS and Health Fund: Foundation for Action or Fig Leaf?

Oxfam paper. Mohga Kamal Smith (2000) 

What do the Poor Say? Using Participatory Rural Appraisal to Find Out Poor People's Perceptions on Poverty and Health. 

A paper presented at the Qualitative Evidence-Based Practice Conference. Coventry University (unpublished). Mohga Kamal Smith (2000) 

Hospitals in Developing Countries: A Week Link in a Weak Chain

The Lancet Vol. 354, Supplement. Mohga Kamal Smith (1999) 

Poverty, Inequality, and Health: What do Poor People Say?

A paper presented for the LSHTM conference on poverty and inequality (unpublished). Mohga Kamal Smith (1999)

Health Sector Reforms: Background Information In Report on Delhi Workshop

Oxfam internal publication. ​​​​Mohga Kamal Smith (1998)

The Effectiveness of Growth Monitoring on the Nutritional Status of Children Under Five in Poor Urban Communities in the Developing World

MPhil dissertation University of Bristol (unpublished). Mohga Kamal Smith (1997) 

Gender and Health, Some Views from Oxfam Experience

The Gender Network newsletter; The British Council. Mohga Kamal Smith (1997) 

Talking Garbage – Women and Urban Health

The Health Exchange. Mohga Kamal Smith (1996) 

NGOs and Smooth Information Flow

Liaison WHO publication. Mohga Kamal Smith (1996) 

ghp logo3.png

Global Health Policy

  • Facebook
  • LinkedIn
  • X

©2019 by Mohga Kamal-Yanni

bottom of page